RESUMEN
Percutaneous mitral valvotomy is an alternative to surgery for the treatment of selected patients with mitral stenosis. With the purpose of reviewing our own experience and to determine the relationship of several variables with procedural success or complications rate, we have analyzed the immediate results of 335 consecutive procedures (90% with the Inoue balloon). Mean age was 51 +/- 12 years, 79% were female, 59% were in atrial fibrillation, 49% in NYHA class > or = III and 34% had mild mitral regurgitation. Mean echocardiographic score was 7.6 +/- 1.9 and up to 25% of patients had a total score > or = 8. Mean mitral valve area (Gorlin) increased from 0.94 +/- 0.2 to 1.87 +/- 0.5 cm2, with increments > or = 50% in mitral area in 88% and a final area > or = 1.5 cm2 in 85% of patients. Patients with an score > 8 obtained smaller mitral areas (1.64 +/- 0.4 vs 1.95 +/- 0.5 cm2. p < 0.01), and a higher percent of suboptimal (< 1.5 cm2) mitral area (22 vs 2%, p < 0.001) than patients with a lower score. Echocardiographic score (p = 0.009), balloon size (p = 0.01) and left atrial diameter (p = 0.04) were identified as independent predictors of a post-procedural mitral area > or = 1.5 cm2. Complications including cardiac tamponade (3 cases), cerebral ischemic events (1 case) and death (1 case) were rare. Mitral regurgitation increased by 2 or more grades in 14%, but regurgitation was severe in only 6% and early mitral surgery was required in 6 (2%) patients. No clinical, anatomical or procedural variables were found to be predictors of a significant increase in mitral regurgitation, a complication which occurred even in valves with a low echocardiographic score. In conclusion, percutaneous mitral valvotomy is a safe and effective procedure for the treatment of selected patients with mitral stenosis. Since complications, even if rare might be serious, the procedure should be performed only in symptomatic patients.
Asunto(s)
Oclusión con Balón , Cateterismo/métodos , Hospitales Universitarios , Válvula Mitral , Adulto , Anciano , Anciano de 80 o más Años , Cateterismo/efectos adversos , Cateterismo/estadística & datos numéricos , Ecocardiografía Doppler/estadística & datos numéricos , Femenino , Hospitales Universitarios/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Válvula Mitral/diagnóstico por imagen , Estenosis de la Válvula Mitral/diagnóstico por imagen , Estenosis de la Válvula Mitral/epidemiología , Estenosis de la Válvula Mitral/terapia , Análisis Multivariante , Estudios Prospectivos , Cardiopatía Reumática/diagnóstico por imagen , Cardiopatía Reumática/epidemiología , Cardiopatía Reumática/terapia , España/epidemiología , Insuficiencia del TratamientoRESUMEN
El presente artículo resume nuestros conocimientos actuales en algunos procederes alternativos a la cirugía a la hora de tratar la estenosis aórtica degenerativa. La valvuloplastia aórtica sólo puede ser recomendada como 'tratamiento puente' en pacientes que, de forma inmediata, vayan a ser operados. La utilización del láser ofrece unas perspectivas prometedoras no consolidadas todavía. Lo mismo cabe decir en la implantación percutánea de una prótesis aórtica. Finalmente, se hace énfasis en la importancia de controlar los factores de riesgo de la estenosis aórtica degenerativa, que son prácticamente los mismos de los de la enfermedad aterotrombótica (AU)